KM-BVs detected | Overall positivity | Total samples (n=213) | All KM-BV-positive samples (n=155) |
N | (%) | (%) | |
Overall KM-BVs detection | 155 | 72.8 | 100 |
Gardnerella vaginalis | 72 | 33.8 | 46.4 |
Ureaplasma urealyticum | 27 | 12.7 | 17.4 |
Megasphaera type I | 48 | 22.5 | 31 |
BVAB1 | 33 | 15.5 | 21.3 |
BVAB3 | 27 | 12.7 | 17.4 |
Mobiluncus curtisii | 20 | 9.4 | 12.9 |
BVAB2 | 19 | 8.9 | 12.2 |
Atopobium vaginae | 14 | 6.5 | 9 |
Mycoplasma hominis | 9 | 4.2 | 5.8 |
Sneathia sanguinegens | 9 | 4.2 | 5.8 |
Mobiluncus mulieris | 6 | 2.8 | 3.9 |
Bacteroides fragilis | 4 | 1.9 | 2.6 |
Mycoplasma genitalium | 2 | 0.9 | 1.3 |
KM-BVs single infections | 74 | 34.7 | 47.4 |
Gardnerella vaginalis | 31 | 14.5 | 20 |
Megasphaera type I | 13 | 6.1 | 8.4 |
Ureaplasma urealyticum | 11 | 5.1 | 7.1 |
Mobiluncus curtisii | 5 | 2.3 | 3.2 |
Mycoplasma hominis | 4 | 1.9 | 2.6 |
BVAB1 | 3 | 1.4 | 1.9 |
BVAB3 | 2 | 0.9 | 1.3 |
Bacteroides fragilis | 2 | 0.9 | 1.3 |
BVAB2 | 1 | 0.4 | 0.6 |
Atopobium vaginae | 1 | 0.4 | 0.6 |
Mycoplasma genitalium | 1 | 0.4 | 0.6 |
KM-BVs simultaneous infections | 81 | 38 | 52.2 |
2 KM-BVs | 46 | 21.6 | 29.7 |
3 KM-BVs | 19 | 8.9 | 12.2 |
4 KM-BVs | 13 | 6.1 | 8.4 |
5 KM-BVs | 2 | 0.9 | 12.9 |
6 KM-BVs | 1 | 0.5 | 0.6 |
BVAB1, 2, 3, Clostridia-like bacteria vaginosis-associated bacteria 1, 2, and 3.; KM-BVs, key markers of bacterial vaginosis.